Exploring user narratives of self-medicated black market IPED use for therapeutic & wellbeing purposes

Antonopoulos, 2016, Gain with no pain’: anabolic-androgenic steroids trafficking in the UK, European Journal of Criminology, 13, 696, 10.1177/1477370816633261 Askew, 2020, Rethinking enhancement substance use: a critical discourse studies approach, International Journal of Drug Policy, 102994 Atkinson, 2021, Performance and image enhancing drug interventions aimed at increasing knowledge among healthcare professionals (HCP): reflections on the implementation of the Dopinglinkki e-module in Europe and Australia in the HCP workforce, International Journal of Drug Policy, 10.1016/j.drugpo.2021.103141 Barkoukis, 2015, Nutritional supplement and doping use in sport: possible underlying social cognitive processes, Scandinavian Journal of Medicine & Science in Sports, 25, 582, 10.1111/sms.12377 Bates, 2021, Looking beyond the provision of injecting equipment to people who use anabolic androgenic steroids: harm reduction and behavior change goals for UK policy, Contemporary Drug Problems, 10.1177/0091450921998701 Begley, 2017 Blackman, 2016, The Emotional Imagination: Exploring critical ventriloquy and emotional edgework in reflexive sociological ethnography with young people, 77 Boardley, 2019, Licit forms of Performance enhancement and possible links with IPED use: current knowledge and future directions Bonnecaze, 2021, Harm reduction in male patients actively using anabolic androgenic steroids (aas) and performance-enhancing drugs (PEDs): a review, Journal of General Internal Medicine, 1 Brennan, 2018, Raw juicing” – an online study of the home manufacture of anabolic androgenic steroids (AAS) for injection in contemporary performance and image enhancement (PIED) culture, Performance Enhancement & Health, 6, 21, 10.1016/j.peh.2017.11.001 Brennan, 2018, Blood letting”—Self-phlebotomy in injecting anabolic-androgenic steroids within performance and image enhancing drug (PIED) culture, International Journal of Drug Policy, 55, 47, 10.1016/j.drugpo.2018.02.011 Charmaz, 2014 Christiansen, 2017, Outline of a typology of men's use of anabolic androgenic steroids in fitness and strength training environments, Drugs: Education, Prevention and Policy, 24, 295 Coomber, 2014, The supply of steroids and other performance and image enhancing drugs (PIEDs) in one English city: fakes, counterfeits, supplier trust, common beliefs and access, Performance Enhancement & Health, 3, 135, 10.1016/j.peh.2015.10.004 Coomber, 2019, The supply of image and performance enhancing drugs (IPED) to local non-elite users in England: Resilient traditional and newly emergent methods, 230 Corroon, 2017, Cannabis as a substitute for prescription drugs–a cross-sectional study, Journal of Pain Research, 10, 989, 10.2147/JPR.S134330 Csatari, 2014, The high price of low testosterone, Men's Health Duchaine, 1989 Dunn, 2016, Do performance and image enhancing drug users in regional Queensland experience difficulty accessing health services?, Drug & Alcohol Review, 35, 377, 10.1111/dar.12363 Dunn, 2021, The pharmaceuticalisation of ‘healthy’ ageing: testosterone enhancement for longevity, International Journal of Drug Policy, 10.1016/j.drugpo.2021.103159 Enghoff, 2019, The value of unsolicited online data in drug policy research, International Journal of Drug Policy, 73, 210, 10.1016/j.drugpo.2019.01.023 Evans, 2004, Current concepts in anabolic-androgenic steroids, The American Journal of Sports Medicine, 32, 534, 10.1177/0363546503262202 Evans-Brown, 2012 Falqueto, 2021, Can conditions of skeletal muscle loss be improved by combining exercise with anabolic–androgenic steroids? A systematic review and meta-analysis of testosterone-based interventions, Reviews in Endocrine and Metabolic Disorders, 1 Fox, 2008, Pharma in the bedroom... and the kitchen.... The pharmaceuticalisation of daily life, Sociology of Health & Illness, 30, 856, 10.1111/j.1467-9566.2008.01114.x Germain, 2020, 2, 4 dinitrophenol: it's not just for men, International Journal of Drug Policy, 102987 Gibbs, 2021, Digital ethnography in criminology: Some notes from the virtual field, 283 Glaser, 1967 Graham, 2009, Counterfeiting in performance-and image-enhancing drugs, Drug Testing and Analysis, 1, 135, 10.1002/dta.30 Hall, 2016 Harris, 2002, The correspondence method as a data-gathering technique in qualitative enquiry, International Journal of Qualitative Methods, 1, 1, 10.1177/160940690200100401 Harrison, 2000, Medical autonomy and the UK state 1975 to 2025, Sociology, 34, 129, 10.1177/S0038038500000092 Harvey, 2019, Support for non-prescribed anabolic androgenic steroids users: a qualitative exploration of their needs, Drugs: Education, Prevention & Policy, 27, 377 Harvey, 2019, Support for people who use anabolic androgenic steroids: a systematic scoping review into what they want and what they access, BMC Public Health, 19, 1, 10.1186/s12889-019-7288-x Harvey, 2021, Libido as a motivator for starting and restarting non-prescribed anabolic androgenic steroid use among men: a mixed-methods study, Drugs: Education, Prevention and Policy Hazekamp, 2014, Self-medication with cannabis, 319 Henning, 2019, Yay, another lady starting a log!”: women's fitness doping and the gendered space of an online doping forum, Communication & Sport Hoberman, 2005 Hurst, 2019, Sport supplement use predicts doping attitudes and likelihood via sport supplement beliefs, Journal of sports sciences, 37, 1734, 10.1080/02640414.2019.1589920 Johnstad, 2018, Powerful substances in tiny amounts: an interview study of psychedelic microdosing, Nordic Studies on Alcohol and Drugs, 35, 39, 10.1177/1455072517753339 Kimergård, 2014, Variability and dilemmas in harm reduction for anabolic steroid users in the UK: a multi-area interview study, Harm Reduction Journal, 11 Kimergård, 2014, Online marketing of synthetic peptide hormones: poor manufacturing, user safety, and challenges to public health, Drug Testing and Analysis, 6, 396, 10.1002/dta.1636 Liokaftos, 2021, Sociological investigations of human enhancement drugs: the case of microdosing psychedelics, International Journal of Drug Policy, 103099 Lucas, 2017, Rationale for cannabis-based interventions in the opioid overdose crisis, Harm Reduction Journal, 14, 1, 10.1186/s12954-017-0183-9 Lucas, 2017, Medical cannabis access, use, and substitution for prescription opioids and other substances: a survey of authorized medical cannabis patients, International Journal of Drug Policy, 42, 30, 10.1016/j.drugpo.2017.01.011 Martin, 2021, A critical evaluation of percussion massage gun devices as a rehabilitation tool focusing on lower limb mobility: a literature review, SportRxiv May, 2020, Not what the doctor ordered: motivations for nonmedical prescription drug use among people who use illegal drugs, International Journal of Drug Policy, 82, 10.1016/j.drugpo.2020.102823 Maycock, 2021, ‘Covid-19 has caused a dramatic change to prison life’. Analysing the impacts of the Covid-19 pandemic on the pains of imprisonment in the Scottish Prison Estate, The British Journal of Criminology McVeigh, J., & Begley, E. (2017). Anabolic steroids in the UK: An increasing issue for public health. Drugs: Education, prevention and policy, 24(3), 278–285. 10.1080/09687637.2016.1245713. Monaghan, 1999, Challenging medicine? Bodybuilding, drugs and risk, Sociology of Health & Illness, 21, 707, 10.1111/1467-9566.00180 Monaghan, 2001 Pedersen, 1991, Adolescents and benzodiazepines: prescribed use, self-medication and intoxication, Acta Psychiatrica Scandinavica, 84, 94, 10.1111/j.1600-0447.1991.tb01427.x Pope, 2014, Adverse health consequences of performance-enhancing drugs: an endocrine society scientific statement, Endocrine Reviews, 35, 341, 10.1210/er.2013-1058 Pope, 2003, Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial, American Journal of Psychiatry, 160, 105, 10.1176/appi.ajp.160.1.105 Pope, 2004, Anabolic steroid users’ attitudes towards physicians, Addiction, 99, 1189, 10.1111/j.1360-0443.2004.00781.x Power, 2014 Richardson, 2019, Anabolic-androgenic steroids (AAS) users on AAS use: negative effects, “code of silence”, and implications for forensic and medical professionals, Journal of Forensic and Legal Medicine, 68, 10.1016/j.jflm.2019.101871 Sagoe, 2015, Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis, Substance Abuse Treatment, Prevention, and Policy, 10, 1, 10.1186/s13011-015-0006-5 Salinas, 2019, Polydrug use and polydrug markets amongst image and performance enhancing drug users: implications for harm reduction interventions and drug policy, International Journal of Drug Policy, 67, 43, 10.1016/j.drugpo.2019.01.019 Schneider, 1998 Seidman, 1998, Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression, Journal of Affective Disorders, 48, 157, 10.1016/S0165-0327(97)00168-7 Turnock, 2018, and Turnock, 2021, Polydrug use and drug market intersections within powerlifting cultures in remote South-West England, Performance Enhancement & Health, 8, 10.1016/j.peh.2021.100186 Turnock, 2021 Underwood, 2017, Exploring the social lives of image and performance enhancing drugs: an online ethnography of the Zyzz fandom of recreational bodybuilders, International Journal of Drug Policy, 39, 78, 10.1016/j.drugpo.2016.08.012 Underwood, 2020, Testing the boundaries: self-medicated testosterone replacement and why it is practised, International Journal of Drug Policy, 103087 van de Ven, 2021, Identifying best-practice amongst health professionals who work with people using image and performance enhancing drugs (IPEDs) through participatory action research, Qualitative Research in Sport, Exercise and Health, 1 van de Ven, 2021, Illicit performance and image enhancing drug markets in the Netherlands and Belgium, 18 van de Ven, 2020, Human enhancement drugs and new (?) research directions, Performance Enhancement & Health, 7 van de Ven, 2017, Exploring the relationship between online buyers and sellers of image and performance enhancing drugs (IPEDs): quality issues, trust and self-regulation, International Journal of Drug Policy, 50, 48, 10.1016/j.drugpo.2017.09.004 van de Ven, 2019 van de Ven, 2017, Social suppliers: exploring the cultural contours of the performance and image enhancing drug (PIED) market among bodybuilders in the Netherlands and Belgium, International Journal of Drug Policy, 40, 6, 10.1016/j.drugpo.2016.07.009 Vinther, 2019, Different users, different interventions: on the ideal typology of anabolic-androgenic steroid use and its implications for prevention, harm reduction and treatment, 249 Watson, 2000 Zahnow, 2018, Identifying a typology of men who use anabolic androgenic steroids (AAS), International Journal of Drug Policy, 55, 105, 10.1016/j.drugpo.2018.02.022 Zarrouf, 2009, Testosterone and depression, Journal of Psychiatric Practice, 15, 289, 10.1097/01.pra.0000358315.88931.fc